Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
QURE · against 1,216 other Healthcare companies
Ranked #907 of 1,217 · scores higher than 25% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 20–29, including QURE · Click a bar to see the companies
Mainly because of its 3-year revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
| Metric | QURE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 30.2% | 6.1% | 86% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -45.0% | 5.8% | 2% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 907 | 3.1B EUR (≈$3.4B) | 25 | 42 | |
| 907 | 10.0B USD | 25 | 43 | |
| 907 | 16.9B THB (≈$474M) | 25 | 65 | |
| 907 | 2.3B USD | 25 | 52 | |
| 907 | 1.7B USD | 25 | 30 | |
| 907 | 15.6B SEK (≈$1.6B) | 25 | 42 | |
| 920 | 172.4B KRW (≈$124M) | 24 | 26 | |
| 920 | 144.4B KRW (≈$104M) | 24 | 56 | |
| 920 | 2.3B CNY (≈$318M) | 24 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score